Simon Haefliger
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 8
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Hematology top 10%
-
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 4
- Cancer Treatment and Pharmacology 3
-
- Nanoparticle-Based Drug Delivery 5
-
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- Beatrice U. MuellerThomas PabstJulian SchardtMarianne EyholzerRory JohnsonMichela CoanSamir OunzainNikolai A. Timchenko
- Cited by
- Cancer ResearchHematologyGenetics
- Journals
- Journal of Clinical Oncology (7 papers)Journal of Thoracic Oncology (2 papers)Blood (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Simon Haefliger
32 papers receiving 591 citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Cancer Research 204
- Hematology 135
- Genetics 65
- Molecular Biology 342
- Cell Biology 49
Countries citing papers authored by Simon Haefliger
This map shows the geographic impact of Simon Haefliger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Haefliger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Haefliger more than expected).
Fields of papers citing papers by Simon Haefliger
This network shows the impact of papers produced by Simon Haefliger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Haefliger. The network helps show where Simon Haefliger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Simon Haefliger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 18 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 20 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 2 | |
| 16 | 2020 | 1 | |
| 17 | 2016 | 38 | |
| 18 | 2010 | 29 | |
| 19 | 2010 | 50 | |
| 20 | 2009 | 56 |
About Simon Haefliger
Simon Haefliger is a scholar working on Cancer Research, Oncology and Biomaterials, having authored 33 papers that have together received 604 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Nanoparticle-Based Drug Delivery (5 papers), Cancer-related molecular mechanisms research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), CAR-T cell therapy research (4 papers), MicroRNA in disease regulation (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Cancer Research (204 citations), Hematology (135 citations) and Genetics (65 citations). Simon Haefliger has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Beatrice U. Mueller, Thomas Pabst, Julian Schardt, Marianne Eyholzer, Rory Johnson, Michela Coan, Samir Ounzain, Nikolai A. Timchenko, Milton J. Finegold and Sabine Schmid. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Blood, British Journal of Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.